vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Liberty Energy Inc. (LBRT). Click either name above to swap in a different company.

Liberty Energy Inc. is the larger business by last-quarter revenue ($1.0B vs $962.7M, roughly 1.1× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs 2.2%, a 5.5% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 4.5%). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -6.2%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Liberty Energy Inc. is a North American energy services provider specializing in hydraulic fracturing and well completion solutions for oil and gas operators. It serves clients across major U.S. shale basins, offering low-emission equipment and tailored support to optimize well productivity.

ATR vs LBRT — Head-to-Head

Bigger by revenue
LBRT
LBRT
1.1× larger
LBRT
$1.0B
$962.7M
ATR
Growing faster (revenue YoY)
ATR
ATR
+9.0% gap
ATR
13.5%
4.5%
LBRT
Higher net margin
ATR
ATR
5.5% more per $
ATR
7.7%
2.2%
LBRT
Faster 2-yr revenue CAGR
ATR
ATR
Annualised
ATR
2.6%
-6.2%
LBRT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ATR
ATR
LBRT
LBRT
Revenue
$962.7M
$1.0B
Net Profit
$74.3M
$22.6M
Gross Margin
Operating Margin
11.0%
2.2%
Net Margin
7.7%
2.2%
Revenue YoY
13.5%
4.5%
Net Profit YoY
-26.4%
EPS (diluted)
$1.13
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
LBRT
LBRT
Q1 26
$1.0B
Q4 25
$962.7M
$1.0B
Q3 25
$961.1M
$947.4M
Q2 25
$966.0M
$1.0B
Q1 25
$887.3M
$977.5M
Q4 24
$848.1M
$943.6M
Q3 24
$909.3M
$1.1B
Q2 24
$910.1M
$1.2B
Net Profit
ATR
ATR
LBRT
LBRT
Q1 26
$22.6M
Q4 25
$74.3M
$13.7M
Q3 25
$127.9M
$43.1M
Q2 25
$111.7M
$71.0M
Q1 25
$78.8M
$20.1M
Q4 24
$100.9M
$51.9M
Q3 24
$100.0M
$73.8M
Q2 24
$90.5M
$108.4M
Gross Margin
ATR
ATR
LBRT
LBRT
Q1 26
Q4 25
20.6%
Q3 25
18.7%
Q2 25
22.1%
Q1 25
22.1%
Q4 24
21.4%
Q3 24
26.2%
Q2 24
27.9%
Operating Margin
ATR
ATR
LBRT
LBRT
Q1 26
2.2%
Q4 25
11.0%
1.9%
Q3 25
14.2%
-0.3%
Q2 25
14.9%
3.6%
Q1 25
12.8%
1.9%
Q4 24
14.2%
2.6%
Q3 24
15.2%
9.4%
Q2 24
13.8%
12.2%
Net Margin
ATR
ATR
LBRT
LBRT
Q1 26
2.2%
Q4 25
7.7%
1.3%
Q3 25
13.3%
4.5%
Q2 25
11.6%
6.8%
Q1 25
8.9%
2.1%
Q4 24
11.9%
5.5%
Q3 24
11.0%
6.5%
Q2 24
9.9%
9.3%
EPS (diluted)
ATR
ATR
LBRT
LBRT
Q1 26
$0.14
Q4 25
$1.13
$0.08
Q3 25
$1.92
$0.26
Q2 25
$1.67
$0.43
Q1 25
$1.17
$0.12
Q4 24
$1.48
$0.31
Q3 24
$1.48
$0.44
Q2 24
$1.34
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
LBRT
LBRT
Cash + ST InvestmentsLiquidity on hand
$409.5M
$699.1M
Total DebtLower is stronger
$1.1B
$7.1M
Stockholders' EquityBook value
$2.7B
$1.9B
Total Assets
$5.3B
$4.4B
Debt / EquityLower = less leverage
0.43×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
LBRT
LBRT
Q1 26
$699.1M
Q4 25
$409.5M
$27.6M
Q3 25
$264.8M
$13.5M
Q2 25
$169.8M
$19.6M
Q1 25
$136.8M
$24.1M
Q4 24
$226.2M
$20.0M
Q3 24
$327.9M
$23.0M
Q2 24
$223.9M
$30.0M
Total Debt
ATR
ATR
LBRT
LBRT
Q1 26
$7.1M
Q4 25
$1.1B
$246.6M
Q3 25
$546.0M
Q2 25
$535.1M
Q1 25
$561.2M
Q4 24
$688.1M
$190.5M
Q3 24
$822.7M
Q2 24
$681.5M
Stockholders' Equity
ATR
ATR
LBRT
LBRT
Q1 26
$1.9B
Q4 25
$2.7B
$2.1B
Q3 25
$2.8B
$2.1B
Q2 25
$2.7B
$2.0B
Q1 25
$2.5B
$2.0B
Q4 24
$2.5B
$2.0B
Q3 24
$2.5B
$2.0B
Q2 24
$2.4B
$1.9B
Total Assets
ATR
ATR
LBRT
LBRT
Q1 26
$4.4B
Q4 25
$5.3B
$3.6B
Q3 25
$5.1B
$3.5B
Q2 25
$4.9B
$3.4B
Q1 25
$4.5B
$3.4B
Q4 24
$4.4B
$3.3B
Q3 24
$4.6B
$3.3B
Q2 24
$4.5B
$3.2B
Debt / Equity
ATR
ATR
LBRT
LBRT
Q1 26
0.00×
Q4 25
0.43×
0.12×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
0.10×
Q3 24
0.32×
Q2 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
LBRT
LBRT
Operating Cash FlowLast quarter
$183.7M
Free Cash FlowOCF − Capex
$96.9M
FCF MarginFCF / Revenue
10.1%
Capex IntensityCapex / Revenue
9.0%
13.1%
Cash ConversionOCF / Net Profit
2.47×
TTM Free Cash FlowTrailing 4 quarters
$299.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
LBRT
LBRT
Q1 26
Q4 25
$183.7M
$195.4M
Q3 25
$177.6M
$51.5M
Q2 25
$126.0M
$170.6M
Q1 25
$82.7M
$192.1M
Q4 24
$178.2M
$177.3M
Q3 24
$229.3M
$244.5M
Q2 24
$143.6M
$248.2M
Free Cash Flow
ATR
ATR
LBRT
LBRT
Q1 26
Q4 25
$96.9M
$-10.0M
Q3 25
$114.3M
$-67.2M
Q2 25
$62.5M
$33.1M
Q1 25
$25.9M
$58.2M
Q4 24
$112.2M
$-26.2M
Q3 24
$162.7M
$77.9M
Q2 24
$75.4M
$112.2M
FCF Margin
ATR
ATR
LBRT
LBRT
Q1 26
Q4 25
10.1%
-1.0%
Q3 25
11.9%
-7.1%
Q2 25
6.5%
3.2%
Q1 25
2.9%
6.0%
Q4 24
13.2%
-2.8%
Q3 24
17.9%
6.8%
Q2 24
8.3%
9.7%
Capex Intensity
ATR
ATR
LBRT
LBRT
Q1 26
13.1%
Q4 25
9.0%
19.8%
Q3 25
6.6%
12.5%
Q2 25
6.6%
13.2%
Q1 25
6.4%
13.7%
Q4 24
7.8%
21.6%
Q3 24
7.3%
14.6%
Q2 24
7.5%
11.7%
Cash Conversion
ATR
ATR
LBRT
LBRT
Q1 26
Q4 25
2.47×
14.28×
Q3 25
1.39×
1.20×
Q2 25
1.13×
2.40×
Q1 25
1.05×
9.55×
Q4 24
1.77×
3.42×
Q3 24
2.29×
3.31×
Q2 24
1.59×
2.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

LBRT
LBRT

Segment breakdown not available.

Related Comparisons